Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

SpyGlass Pharma, Inc.

NASDAQ: SGP · Industrial Applications and Services · 4 alerts · CIK 1778922

Share price
$32.24Close, Nov 16
Market cap
$1.08B
Shares outstanding
33.46MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All SpyGlass Pharma, Inc. filings on SEC EDGAR ↗

4:10 PM ET 8-K
Clinical Trial Data

SpyGlass Pharma Clinical Trial Data

SpyGlass Pharma announced positive 4-year interim results from its first-in-human trial of the BIM-IOL System for glaucoma patients undergoing cataract surgery. The data showed a 37% reduction in mean intraocular pressure and 86% of patients remained off topical drops with no product-related adverse events reported.

Term
4 years
8:16 AM ET 8-K
M&A Deal

SpyGlass Pharma Signs $13M M&A Deal with Advanced Vision Science, Inc.

SpyGlass Pharma acquired 100% of the equity of Advanced Vision Science, Inc. (AVS) from Santen Holdings US for approximately $13 million in cash. The deal secures internal manufacturing capacity for the intraocular lenses (IOL) used in SpyGlass's Phase 3 drug delivery system and includes a supply agreement to continue providing products to Santen in Japan.

Value
$13M
Counterparty
Advanced Vision Science, Inc.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.